Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q4 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.